520A Stock Chart & Stats
$467.00
-$48.00(-9.32%)
―
--
Day’s Range― - ―
52-Week Range$260.00 - $809.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)376.00K
Market Cap
¥9.29B
Enterprise Value$1.76K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.45
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding18,041,466
10 Day Avg. Volume1,060,030
30 Day Avg. Volume376,003
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
J-Pharma Co.,Ltd. News
520A FAQ
What was J-Pharma Co.,Ltd.’s price range in the past 12 months?
J-Pharma Co.,Ltd. lowest stock price was $260.00 and its highest was $809.00 in the past 12 months.
What is J-Pharma Co.,Ltd.’s market cap?
J-Pharma Co.,Ltd.’s market cap is ¥9.29B.
When is J-Pharma Co.,Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were J-Pharma Co.,Ltd.’s earnings last quarter?
Currently, no data Available
Is J-Pharma Co.,Ltd. overvalued?
According to Wall Street analysts J-Pharma Co.,Ltd.’s price is currently Undervalued.
Does J-Pharma Co.,Ltd. pay dividends?
J-Pharma Co.,Ltd. does not currently pay dividends.
What is J-Pharma Co.,Ltd.’s EPS estimate?
J-Pharma Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does J-Pharma Co.,Ltd. have?
J-Pharma Co.,Ltd. has 18,041,466 shares outstanding.
What happened to J-Pharma Co.,Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of J-Pharma Co.,Ltd.?
Currently, no hedge funds are holding shares in JP:520A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
J-Pharma Co.,Ltd.
J-Pharma Co., Ltd. is engaged in drug discovery and development, focusing on amino acid transporters as drug targets. The company researches and develops drugs targeting solute carrier (SLC) transporters, with emphasis on the LAT1 amino acid transporter. It is developing several compounds for various medical indications, including JPH034 for central nervous system demyelinating diseases and multiple sclerosis. The company conducts functional and structural analysis of selected SLC transporters to support drug discovery, collaborates with academic institutions, and participates in joint research for new pharmaceutical development. It is preparing for clinical trials and global distribution of its drug candidates. The company was founded in 2005 and is based in Yokohama, Japan.
Technical Analysis
AnGes
―
Solasia Pharma KK
―
Nippon Chemiphar Co., Ltd.
―
JCR Pharmaceuticals Co., Ltd.
―
Delta-Fly Pharma, Inc.
―